XML 33 R21.htm IDEA: XBRL DOCUMENT
v3.21.2

Concentrations | 12 Months Ended
--- | ---
Jun. 30, 2021
Concentrations [Abstract] |
Concentrations | 15. CONCENTRATIONS In the year ended June 30, 2021, the Company’s largest customer was Ingram Micro. In the year ended June 30, 2020, the largest customer was Walmart. The Company’s sales to Ingram Micro, were approximately 18% and 10% of net sales in fiscal year 2021 and 2020, respectively. Walmart sales were approximately 6% and 18% of net sales in fiscal year 2021 and 2020, respectively. Amazon, the second largest customer in 2021 and 2020, was approximately 10% and 11% of net sales in fiscal years 2021 and 2020, respectively. The five largest customers of the Company (including Ingram Micro and Amazon in both years) accounted for approximately 48% of net sales in both fiscal years 2021 and 2020. Accounts receivable from Ingram Micro as of June 30, 2021 and June 30, 2020, represented approximately 24% and 9% of trade account receivables, respectively. Amazon accounts receivable as of June 30, 2021 and June 30, 2020, were 19% and 17% of trade accounts receivables, respectively. Accounts receivable from Walmart as of June 30, 2021 and 2020, represented approximately 1% and 8%, respectively. The majority of international customers, outside of Canada, purchase products on a cash against documents or cash in advance basis. Approximately 6% and 11% of the Company's trade accounts receivable at June 30, 2021 and 2020, were foreign receivables denominated in U.S. dollars. The Company uses contract manufacturing facilities in the People’s Republic of China. The majority of the contract manufacturing is done by four vendors with one vendor representing approximately 52% and 70% of the manufacturing costs in fiscal years 2021 and 2020, repsectively. The Company has a long-term relationship with this vendor. However, increased costs from the vendor or an interruption of supply from this vendor could have a material adverse effect on the Company's profit margins and profitability.

X
- Definition The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -URI http://asc.fasb.org/topic&trid=2134479 + Details
Name: | us-gaap_ConcentrationRiskDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RisksAndUncertaintiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration